Business
Sanofi to buy Vicebio for up to US$1.6 billion in vaccine push
The French drugmaker will pay US$1.15 billion upfront with a commitment for potential milestones worth as much as US$450 million Sanofi…
Tag
The French drugmaker will pay US$1.15 billion upfront with a commitment for potential milestones worth as much as US$450 million Sanofi…
France’s Sanofi has agreed to buy US-based Blueprint Medicines Corporation for up to US$9.5 billion to boost its position in rare…
SANOFI said it will repurchase five billion euros (S$7 billion) of stock and grow profits more quickly this year as the drugmaker pivots…